Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats

European Journal of Pharmacology

Volumn 769, Issue , 2015, Pages 313-323

  Paterniti, Irene ^a   Di Paola, Rosanna ^a   Campolo, Michela ^a   Siracusa, Rosalba ^a   Cordaro, Marika ^a   Bruschetta, Giuseppe ^a   Tremolada, Gemma ^c   Maestroni, Anna ^d   Bandello, Francesco ^c   Esposito, Emanuela ^a   Zerbini, Gianpaolo ^d   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Diabetic retinopathy; Inflammation; Palmitoylethanolamide; Streptozotocin

Indexed keywords

3 NITROTYROSINE; CLAUDIN 5; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; PALMIDROL; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; CLAUDIN; CYTOKINE; ETHANOLAMINE DERIVATIVE; GLUCOSE BLOOD LEVEL; PALMITIC ACID DERIVATIVE; TJP1 PROTEIN, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOWN REGULATION; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RAT; RETINA; RETINITIS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TIGHT JUNCTION; TISSUE LEVEL; ANIMAL; BIOSYNTHESIS; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; INFLAMMATION; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; BODY WEIGHT; CLAUDINS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ETHANOLAMINES; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; PALMITIC ACIDS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84949035546     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.11.035     Document Type: Article

References (37)

1. S.F. Abcouwer, and D.A. Antonetti A role for systemic inflammation in diabetic retinopathy Investig. Ophthalmol. Vis. Sci. 54 2013 2384
2. A.P. Adamis Is diabetic retinopathy an inflammatory disease? Br. J. Ophthalmol. 86 2002 363 365
3. E. Aguilar, M.I. Dorrell, D. Friedlander, R.A. Jacobson, A. Johnson, V. Marchetti, S.K. Moreno, M.R. Ritter, and M. Friedlander Ocular models of angiogenesis Methods Enzymol. 444 2008 115 158
4. L. Aloe, A. Leon, and R. Levi-Montalcini A proposed autacoid mechanism controlling mastocyte behaviour Agents Actions 39 1993 C145 C147
5. D.A. Antonetti, A.J. Barber, L.A. Hollinger, E.B. Wolpert, and T.W. Gardner Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors J. Biol. Chem. 274 1999 23463 23467
6. A.J. Barber, and D.A. Antonetti Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats Invest. Ophthalmol. Vis. Sci. 44 2003 5410 5416
7. N. Cheung, P. Mitchell, and T.Y. Wong Diabetic retinopathy Lancet 376 2010 124 136
8. N.A. Enea, T.M. Hollis, J.A. Kern, and T.W. Gardner Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes Arch. Ophthalmol. 107 1989 270 274
9. E. Esposito, and S. Cuzzocrea Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries CNS Neurol. Disord. Drug. Targets 12 2013 55 61
10. E. Esposito, and S. Cuzzocrea Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma Mini Rev. Med. Chem. 13 2013 237 255
11. W.P. Farquhar-Smith, S.I. Jaggar, and A.S. Rice Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors Pain 97 2002 11 21
12. D. Impellizzeri, A. Ahmad, G. Bruschetta, R. Di Paola, R. Crupi, I. Paterniti, E. Esposito, and S. Cuzzocrea The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats Eur. J. Pharmacol. 761 2015 28 35
13. A.M. Joussen, V. Poulaki, N. Mitsiades, B. Kirchhof, K. Koizumi, S. Dohmen, and A.P. Adamis Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression FASEB J. 16 2002 438 440
14. I. Klaassen, C.J. Van Noorden, and R.O. Schlingemann Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions Prog. Retina Eye Res. 34 2013 19 48
15. B.E. Klein, M.D. Knudtson, M.Y. Tsai, and R. Klein The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: wisconsin epidemiologic study of diabetic retinopathy Arch. Ophthalmol. 127 2009 1175 1182
16. R. Klein, B.E. Klein, S.E. Moss, and K.J. Cruickshanks The wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes Ophthalmology 105 1998 1801 1815
17. T. Koto, K. Takubo, S. Ishida, H. Shinoda, M. Inoue, K. Tsubota, Y. Okada, and E. Ikeda Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells Am. J. Pathol. 170 2007 1389 1397
18. E. Lieth, A.J. Barber, B. Xu, C. Dice, M.J. Ratz, D. Tanase, and J.M. Strother Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn state retina research group Diabetes 47 1998 815 820
19. K. Matsumoto, Y. Sera, Y. Ueki, G. Inukai, E. Niiro, and S. Miyake Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy Diabet. Med. 19 2002 822 826
20. S.E. Moss, R. Klein, and B.E. Klein The 14-year incidence of visual loss in a diabetic population Ophthalmology 105 1998 998 1003
21. D. Navaratna, P.G. McGuire, G. Menicucci, and A. Das Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes Diabetes 56 2007 2380 2387
22. T.T. Nguyen, E. Alibrahim, F.M. Islam, R. Klein, B.E. Klein, M.F. Cotch, S. Shea, and T.Y. Wong Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis Diabet. Care 32 2009 1704 1709
23. K. Noda, S. Nakao, S. Ishida, and T. Ishibashi Leukocyte adhesion molecules in diabetic retinopathy J. Ophthalmol. 2012 2012 279037
24. T.L. Palenski, C.M. Sorenson, and N. Sheibani Inflammatory cytokine-specific alterations in retinal endothelial cell function Microvasc. Res. 89 2013 57 69
25. I. Paterniti, D. Impellizzeri, R. Crupi, R. Morabito, M. Campolo, E. Esposito, and S. Cuzzocrea Molecular evidence for the involvement of PPAR-delta and PPAR-gamma in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma J. Neuroinflammation 10 2013 20
26. G. Roglic, and N. Unwin Mortality attributable to diabetes: estimates for the year 2010 Diabet. Res. Clin. Pract. 87 2010 15 19
27. G. Roglic, N. Unwin, P.H. Bennett, C. Mathers, J. Tuomilehto, S. Nag, V. Connolly, and H. King The burden of mortality attributable to diabetes: realistic estimates for the year 2000 Diabet. Care 28 2005 2130 2135
28. W.J. Schnedl, S. Ferber, J.H. Johnson, and C.B. Newgard STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells Diabetes 43 1994 1326 1333
29. J.C. Sluimer, N. Kisters, K.B. Cleutjens, O.L. Volger, A.J. Horrevoets, L.H. van den Akker, A.P.J. Bijnens, and M.J. Daemen Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery Physiol. Genom. 30 2007 335 341
30. I.M. Stratton, E.M. Kohner, S.J. Aldington, R.C. Turner, R.R. Holman, S.E. Manley, and D.R. Matthews UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis Diabetologia 44 2001 156 163
31. N. Ugurlu, S. Gerceker, F. Yulek, B. Ugurlu, C. Sari, P. Baran, and N. Cagil The levels of the circulating cellular adhesion molecules ICAM-1, VCAM-1 and endothelin-1 and the flow-mediated vasodilatation values in patients with type 1 diabetes mellitus with early-stage diabetic retinopathy Intern. Med. 52 2013 2173 2178
32. C. Urso, E. Hopps, and G. Caimi Adhesion molecules and diabetes mellitus La. Clin. Ter. 161 2010 e17 e24
33. H. Wang, Z. Zheng, Y. Gong, B. Zhu, and X. Xu U83836E inhibits retinal neurodegeneration in early-stage streptozotocin-induced diabetic rats Ophthalmic Res. 46 2011 19 24
34. J. Wang, X. Xu, M.H. Elliott, M. Zhu, and Y.Z. Le Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage Diabetes 59 2010 2297 2305
35. R. Williams, M. Airey, H. Baxter, J. Forrester, T. Kennedy-Martin, and A. Girach Epidemiology of diabetic retinopathy and macular oedema: a systematic review Eye 18 2004 963 983
36. H.Z. Xu, and Y.Z. Le Significance of outer blood-retina barrier breakdown in diabetes and ischemia Investig. Ophthalmol. Vis. Sci. 52 2011 2160 2164
37. L. Zheng, S.J. Howell, D.A. Hatala, K. Huang, and T.S. Kern Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy Diabetes 56 2007 337 345